Status:
UNKNOWN
Dietary Phytoestrogens, Complementary and Alternative Medicine, and Lifestyle in Predicting Survival of Women With Breast Cancer
Lead Sponsor:
University College London Hospitals
Conditions:
Breast Cancer
Eligibility:
FEMALE
Up to 75 years
Brief Summary
RATIONALE: Eating a diet rich in phytoestrogens may slow the growth of breast cancer cells and prevent further tumor progression. Learning about the lifestyles of women with breast cancer, their intak...
Detailed Description
OBJECTIVES: * To determine if phytoestrogen intake affects breast cancer progression and survival in women with breast cancer. * To consider the influence of other phytochemicals on breast cancer pro...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Histologically confirmed invasive primary breast cancer
- Grade I to III disease
- No bilateral disease
- Completed active treatment for primary breast cancer within 9 months to 15 months after diagnosis
- Hormone receptor status not specified
- PATIENT CHARACTERISTICS:
- Menopausal status not specified
- No prior cancer except basal cell carcinoma
- No other concurrent primary cancer
- No cognitive impairment
- No psychological problems (e.g., severe endogenous depression)
- Able to understand English well
- PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Exclusion
Key Trial Info
Start Date :
January 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
2300 Patients enrolled
Trial Details
Trial ID
NCT00691509
Start Date
January 1 2005
Last Update
August 26 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University College Hospital
London, England, United Kingdom, NW1 2BU